Skip to content

The role of stress in relapse of drug addiction

Stressing the brain's pleasure circuit: stress hormones, dopamine and addiction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26544
Enrollment
32
Registered
2015-03-10
Start date
2015-03-25
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

addiction relapse stress recreational drug users healthy controls

Interventions

1.placebo 2. methylphenidate 3. hydrocortisone 4. methylphenidate + hydrocortisone

Sponsors

Forschungszentrum Juelich
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -bloodscreen (normal level) -thyroidal parameters (normal level) -ECG (normal level) -negative drugscreen in urine (Benzodiazepine, Opiate, Amphetamine, Cannabis). -no nephrological or thyroidal diseases in medical history -no metal in the human body -no tattoos -age between 18 and 40 years -Body Mass Index (BMI) between 18 und 28 -no first degree relatives with psychiatric disorders in medical history -no psychiatric or neurological disorders in medical history -righthandedness -native German speakers For women: negative pregnancy test For recreational drug users: experience with psychostimulants

Exclusion criteria

Exclusion criteria: -volunteers who are unable to sign the informed consent -pregnancy -volunteers under the age of 18 years -magnetic metal implants, contraceptive coil, tattoos -colorblindness For recreational drug users: drug addiction or dependence in medical history

Design outcomes

Primary

MeasureTime frame
-imaging results under the influence of a psychostimulant, a stress hormone or both.

Secondary

MeasureTime frame
-behavioural performance on cognitive tasks under the influence of a psychostimulant, a stress hormone or both.

Contacts

Public ContactWendy Bosker
w.bosker@fz-juelich.de

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)